查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571543

临床试验支援服务市场规模、份额、趋势分析报告：按阶段、服务、赞助商、地区、细分市场预测，2024-2030

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase III), By Service, By Sponsor (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

临床试验支持服务市场的成长与趋势：

根据 Grand View Research, Inc. Masu 的最新报告，预计到 2030 年，全球临床试验支援服务市场将达到 371.6 亿美元，2024 年至 2030 年复合年增长率为 7.65%。

提供临床试验支援服务的CRO新兴市场的发展以及製药和生物製药公司在研发方面的巨额投资是推动市场成长的主要因素。该行业受到了 COVID-19 大流行的影响。 2020年，疫情严重扰乱了供应链。然而，成长之路也变得清晰，包括併购和在临床研究中引入数位技术。

相关统计数据包括，85%的临床试验未能招募到足够的参与者，80%的临床试验因招募困难而被推迟，参与者的退出率正在增加。然而，为了克服这个问题，需要一个有吸引力且明确的患者保留策略。知情同意资料易于理解非常重要。根据 CISCRP 调查，后来退出的试验参与者中有 35% 表示知情同意很难理解。美国人的平均学术能力为7至8年级，在将材料提交给IRB（机构审查委员会）之前确保材料的可读性和分析性非常重要。

整个临床试验支援服务产业采用虚拟临床试验是疫情后推动收益成长的关键因素之一。越来越多的临床研究机构正在转向虚拟技术来简化临床研究服务。根据 Veeva 统一临床营运调查的最新年度 CRO 报告，CRO 在加速临床试验并使临床试验现代化方面取得了巨大进展。 Veeva Systems 研究表明，CRO 可以透过采用新技术和数位策略来取代手动任务、打破资讯孤岛并实现临床试验协作，从而简化临床试验执行。

临床试验支援服务市场报告亮点

  • 高成本试验现场管理细分市场以 2023 年超过 45.11% 的销售份额占据市场临床实验。
  • 2023年，III期细分市场在全球市场中占据最大收益占有率，达到54.25%。 III期临床试验涉及大量受试者，因此非常昂贵。此阶段的失败率最高，因为样本大小和研究设计需要在最佳水平上进行复杂的给药。
  • 2023年，製药和生物製药公司将拥有最大的市场占有率，达到70.60%。研发投资的增加和新药的推出主要推动了该领域的市场。
  • 预计亚太地区在预测期内将以 8.68% 的复合年增长率增长最快。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章临床试验支持服务市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验支援服务市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章临床试验支援服务市场：阶段估计与趋势分析

  • 临床试验支援服务市场，按阶段：细分仪表板
  • 临床试验支援服务市场，依阶段：变化分析
  • 2018-2030 年分阶段临床试验支援服务市场估计与预测
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第五章临床试验支援服务市场：服务评估与趋势分析

  • 临床试验支援服务市场，按服务：细分仪表板
  • 临床试验支援服务市场（按服务）：波动分析
  • 2018-2030 年临床试验支援服务市场估计与预测（按服务）
  • 临床试验设施管理
  • 病患招募管理
  • 资料管理
  • 管理人员
  • IRBS
  • 其他的

第六章 临床试验支援服务市场：申办者估计与趋势分析

  • 临床试验支援服务市场，依赞助商：细分仪表板
  • 临床试验支援服务市场，按申办者：变异分析
  • 2018-2030 年临床试验支援服务市场估计与预测（按申办者）
  • 製药和生物製药公司
  • 医疗设备公司
  • 其他的

第七章 临床试验支援服务市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 2023 年企业市场占有率分析
  • 公司简介
    • Charles River Laboratories International, Inc.
    • Wuxi Apptec, Inc
    • Iqvia Holdings, Inc
    • Syneos Health, Inc.
    • Eurofins Scientific
    • PPD, Inc.（Pharmaceutical Product Development）
    • Icon Plc
    • Laboratory Corporation of America Holdings（Labcorp）
    • Alcura
    • Parexel International Corporation
Product Code: GVR-4-68039-475-9

Clinical Trials Support Services Market Growth & Trends:

The global clinical trials support services market is expected to reach USD 37.16 billion by 2030, registering a CAGR of 7.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain to a severe extent in 2020. However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research.

Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail to recruit enough participants, 80% are delayed due to recruiting challenges, and the rate of dropout of participants is increasing. However, to overcome this, a patient retention strategy that is engaging and gives clarity is required. It is critical to ensure that the informed consent materials are simple to grasp. According to a CISCRP study, 35% of trial participants who later dropped out stated that informed consent was difficult to comprehend. An average American is 7th to 8th grade educated, and it is critical to guarantee and analyze the material's readability before submitting it to the Institutional Review Board (IRB).

Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies to streamline their clinical research services. According to the latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements to speed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action to streamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations.

Clinical Trials Support Services Market Report Highlights:

  • The clinical trial site management segment dominated the market with a revenue share of more than 45.11% in 2023. High cost associated with site monitoring and site recruitment is one the key factors for the largest share.
  • The phase III segment accounted for the maximum revenue share of 54.25% in the global market in 2023. Phase III clinical trials are highly expensive due to the involvement of huge subjects. The failure rate in this phase is the highest as the sample size and study design require complex dosing at an optimum level.
  • Pharmaceutical & biopharmaceutical companies dominated the market with the largest market share of 70.60% in 2023. Increasing R&D investments and the introduction of new drugs are primarily driving the segment market.
  • Asia Pacific is projected to be the registered fastest-growing CAGR of 8.68% during the forecast period.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Phase
    • 1.2.2. Service
    • 1.2.3. Sponsor
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Objectives
  • 1.6. Research Methodology
  • 1.7. Information Procurement
    • 1.7.1. Purchased Database
    • 1.7.2. GVR's Internal Database
    • 1.7.3. Secondary Sources
    • 1.7.4. Primary Research
  • 1.8. Information Or Data Analysis
    • 1.8.1. Data Analysis Models
  • 1.9. Market Formulation & Validation
  • 1.10. Model Details
    • 1.10.1. Commodity Flow Analysis
    • 1.10.2. Parent Market Analysis
  • 1.11. List Of Secondary Sources
  • 1.12. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trials Support Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Support Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trials Support Services Market: Phase Estimates & Trend Analysis

  • 4.1. Clinical Trials Support Services Market, By Phase: Segment Dashboard
  • 4.2. Clinical Trials Support Services Market, By Phase: Movement Analysis
  • 4.3. Clinical Trials Support Services Market Estimates & Forecasts, By Phase, 2018-2030
  • 4.4. Phase I
    • 4.4.1. Phase I Market, 2018 to 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market, 2018 to 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market, 2018 to 2030 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Support Services Market: Service Estimates & Trend Analysis

  • 5.1. Clinical Trials Support Services Market, By Service: Segment Dashboard
  • 5.2. Clinical Trials Support Services Market, By Service: Movement Analysis
  • 5.3. Clinical Trials Support Services Market Estimates & Forecasts, By Service, 2018-2030
  • 5.4. Clinical Trial Site Management
    • 5.4.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
  • 5.5. Patient Recruitment Management
    • 5.5.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 5.5.2. Patient recruitment & Registry Services
      • 5.5.2.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 5.5.3. Patient retention
      • 5.5.3.1. Patient Retention Market, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market, 2018 to 2030 (USD Million)
  • 5.6. Data Management
    • 5.6.1. Data Management Market, 2018 to 2030 (USD Million)
  • 5.7. Administrative Staff
    • 5.7.1. Administrative Staff Market, 2018 to 2030 (USD Million)
  • 5.8. IRB
    • 5.8.1. IRB Market, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Support Services Market: Sponsor Estimates & Trend Analysis

  • 6.1. Clinical Trials Support Services Market, By Sponsor: Segment Dashboard
  • 6.2. Clinical Trials Support Services Market, By Sponsor: Movement Analysis
  • 6.3. Clinical Trials Support Services Market Estimates & Forecasts, By Sponsor, 2018-2030
  • 6.4. Pharmaceutical & biopharmaceutical companies
    • 6.4.1. Pharmaceutical & biopharmaceutical companies Market, 2018 to 2030 (USD Million)
  • 6.5. Medical device companies
    • 6.5.1. Medical device companies Market, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trials Support Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2018-2030
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2018-2030
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2018-2030
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2018-2030
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2018-2030
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2018-2030
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2018-2030
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2018-2030
    • 7.4.7. Sweden
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Sweden Market Estimates and Forecasts, 2018-2030
    • 7.4.8. Denmark
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Denmark Market Estimates and Forecasts, 2018-2030
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2018-2030
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2018-2030
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2018-2030
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2018-2030
    • 7.5.5. Thailand
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Thailand Market Estimates and Forecasts, 2018-2030
    • 7.5.6. South Korea
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. South Korea Market Estimates and Forecasts, 2018-2030
    • 7.5.7. Australia
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Australia Market Estimates and Forecasts, 2018-2030
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2018-2030
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2018-2030
    • 7.6.4. Colombia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Colombia Market Estimates and Forecasts, 2018-2030
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2018-2030
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2018-2030
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2018-2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Innovators
    • 8.1.2. Market Leaders
    • 8.1.3. Emerging Players
    • 8.1.4. Company Market Share Analysis, 2023
  • 8.2. Company Profiles
    • 8.2.1. Charles River Laboratories International, Inc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Wuxi Apptec, Inc
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Iqvia Holdings, Inc
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Syneos Health, Inc.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Eurofins Scientific
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. PPD, Inc. (Pharmaceutical Product Development)
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Icon Plc
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Laboratory Corporation of America Holdings (Labcorp)
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Alcura
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Parexel International Corporation
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trials Support Services,by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trials Support Services,by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 11 U.S Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 12 U.S Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 13 U.S Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trials Support Services,by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 25 UK Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 26 UK Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 27 Germany Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 28 Germany Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 29 Germany Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 42 Denmark Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 43 Denmark Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 44 Denmark Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trials Support Services,by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 53 Japan Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 54 Japan Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 55 China Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 56 China Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 57 China Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 61 Thailand Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 62 Thailand Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 64 South Korea Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 65 South Korea Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 66 South Korea Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 67 Australia Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 68 Australia Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 69 Australia Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trials Support Services,by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 80 Colombia Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 81 Colombia Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 82 Colombia Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trials Support Services,by Country, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 87 South Africa Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 88 South Africa Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 89 South Africa Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 93 UAE Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 94 UAE Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 95 UAE Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Clinical Trials Support Services,by Phase, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Clinical Trials Support Services,by Service, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Clinical Trials Support Services,by Sponsor, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Clinical Trials Support Services Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Clinical Trials Support Services Market snapshot
  • Fig. 11 Clinical Trials Support Services Market driver impact
  • Fig. 12 Clinical Trials Support Services Market restraint impact
  • Fig. 13 Clinical Trials Support Services sector key takeaways (USD Million)
  • Fig. 14 Clinical Trials Support Services Market: Phase movement analysis
  • Fig. 15 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 16 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 17 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 18 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 19 Clinical Trials Support Services Market Service key takeaways (USD Million)
  • Fig. 20 Clinical Trials Support Services Market: service movement analysis
  • Fig. 21 Clinical Trial Site Management market, 2018 - 2030 (USD Million)
  • Fig. 22 Patient Recruitment Management market, 2018 - 2030 (USD Million)
  • Fig. 23 Patient recruitment & Registry Services market, 2018 - 2030 (USD Million)
  • Fig. 24 Patient retention market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Data Management market, 2018 - 2030 (USD Million)
  • Fig. 27 Administrative Staff market, 2018 - 2030 (USD Million)
  • Fig. 28 IRB market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trials Support Services Market Sponsor key takeaways (USD Million)
  • Fig. 31 Clinical Trials Support Services Market: sponsor movement analysis
  • Fig. 32 Pharmaceutical & biopharmaceutical companies' market, 2018 - 2030 (USD Million)
  • Fig. 33 Medical device companies' market, 2018 - 2030 (USD Million)
  • Fig. 34 Others market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Regional outlook, 2023 & 2030
  • Fig. 37 North America Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 France Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 China Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 India Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 60 Colombia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East & Africa Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 66 Market participant categorization